| Literature DB >> 29686818 |
Antonio Merico1, Marianna Cavinato1, Caterina Gregorio2, Alessandra Lacatena3, Elisabetta Gioia4, Francesco Piccione1, Corrado Angelini1.
Abstract
Based on available evidence, muscle strengthening and cardiovascular exercises can help maintain function and not adversely affect the progression of disease in patients with ALS. However, this evidence is not sufficiently detailed to recommend a specific exercise prescription. The purpose of this project was to assess clinical outcomes of a combined exercise programme to increase knowledge of rehabilitation in ALS patients. 38 ALS patients were assigned randomly to two groups: one group underwent a specific exercise programme (ALS-EP) based on a moderate aerobic workout and isometric contractions, and the second group followed a standard neuromotor rehabilitation treatment. Objective evaluation consisted of cardiovascular measures, muscle strength and fatigue. Some positive effects of physical activity on ALS patients were found. Among the benefits, an overall improvement of functional independence in all patients, independently of the type of exercise conducted was seen. In addition, improvements in muscle power, oxygen consumption and fatigue were specifically observed in the ALS-EP group, all hallmarks of a training effect for the specific exercises. In conclusion, moderate intensity exercise is beneficial in ALS, helping in avoiding deconditioning and muscle atrophy resulting from progressive inactivity.Entities:
Keywords: Amyotrophic Lateral Sclerosis; endurance training; isometric exercise; neurorehabilitation
Year: 2018 PMID: 29686818 PMCID: PMC5895987 DOI: 10.4081/ejtm.2018.7278
Source DB: PubMed Journal: Eur J Transl Myol ISSN: 2037-7452
Baseline characteristics of exercise programme group (ALS-EP) and standard neuromotor rehabilitation treatment group (ALS-SNT). ALSFS-R, Amyotrophic Lateral Sclerosis Functional Scale- revised; FIM, Functional Independence Measure; FSS, Fatigue Severity Scale; MRC sum score, Medical Research Concil sum score.
| ALS-EP n=23 | ALS-SNT n=15 | |
|---|---|---|
| mean±SD | mean±SD | |
| Age, yr | 61.6 ± 10.6 | 59.8 ± 14.7 |
| Gender, F/M | 10/13 | 4/10 |
| Onset,Spinal/Bulbar | 22/1 | 15/0 |
| Disease duration, mo | 30.2±11.8 | 30.3±6.7 |
| ALSFRS-R | 36.1±4.71 | 34.5±3.6 |
| ALSFRS-R, Bulbar subscore | 9.89±1.7 | 9.73±1.7 |
| Rate of progression | 0.4±0.18 | 0.4±0.05 |
| FIM | 79.73±6.1 | 78.0±8.3 |
| FSS | 5.4±0.27 | 5.4±0.2 |
| Resting heart rate, bpm | 80.52±5.4 | 78.80±8.47 |
| Oxygen Consumption, ml/min/kg | 15.36±2.0 | 12.67±1.60 |
| Ventilation, L/min | 25.95±5.2 | 24.49±5.62 |
| MRC Sum Score | 40.26±2.45 | 39.87±4.24 |
| Right Biceps Muscle, kg/min | 66.96±24.95 | 73.13±16.99 |
| Left Biceps Muscle, kg/min | 70.65±19.53 | 80.27±14.60 |
| Right Tibial Muscle, kg/min | 77.11±34.92 | 57.93±27.74 |
| Left Tibial Muscle, kg/min | 77.21±36.11 | 60.80±32.30 |
| Six Minute Walk Test, mt | 265.17±81.37 | 236.26±76.26 |
The cardiovascular and metabolic data of ALS-SNP patients
| ALS-SNT | age | HR 65% | RHR I | RHR F | VO2 I | VO2 F | 6MW I | 6MW F | MRCss I | MRCSs F |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 54 | 110 | 87 | 85 | 13 | 22,4 | 157,5 | 158,5 | 43 | 46 |
| 2 | 65 | 100 | 91 | 88 | 13,5 | 21 | 157,5 | 158,9 | 42 | 45 |
| 3 | 57 | 110 | 83 | 79 | 13,9 | 19,3 | 172,3 | 172 | 38 | 41 |
| 4 | 58 | 105 | 86 | 84 | 10,4 | 38 | 242 | 242 | 48 | 51 |
| 5 | 57 | 110 | 85 | 81 | 12,4 | 21 | 158 | 157,5 | 42 | 45 |
| 6 | 33 | 120 | 81 | 80 | 9,4 | 23,7 | 250 | 250 | 41 | 43 |
| 7 | 60 | 105 | 82 | 80 | 12 | 24 | 335 | 337 | 39 | 40 |
| 8 | 63 | 95 | 56 | 70 | 15 | 30 | 150 | 170 | 38 | 39 |
| 9 | 29 | 125 | 72 | 75 | 15,1 | 30,2 | 305 | 307 | 44 | 45 |
| 10 | 45 | 115 | 81 | 78 | 18 | 26,6 | 280 | 290 | 38 | 38 |
| 11 | 76 | 95 | 78 | 79 | 11,9 | 17 | 168 | 167 | 36 | 36 |
| 12 | 79 | 90 | 72 | 71 | 11 | 28,2 | 188 | 188 | 36 | 36 |
| 13 | 73 | 95 | 78 | 79 | 12,8 | 26,7 | 275 | 280 | 40 | 41 |
| 14 | 75 | 95 | 78 | 76 | 9,9 | 17 | 270 | 271 | 36 | 36 |
| 15 | 64 | 100 | 72 | 69 | 12,6 | 22,3 | 395 | 398 | 38 | 38 |
Functional and cardiopulmonary changes after training.
| ALS-EP n=23 | ALS-SNT n=15 | |
|---|---|---|
| mean±SD | mean±SD | |
| FIM | 4.56±1.16 | 1.8±1.37 |
| FSS | 1.29±0.21 | -0.21±0.16 |
| Resting heart rate, bpm | -5.7±1.29 | -0.53±4.47 |
| Oxygen Consumption, ml/min/kg | -4.16±1.71 | 0.10±1.53 |
| Ventilation, L/min | -3.59±4.73 | 0.34±4.64 |
| MRC Sum Score | 7.83±1.80 | 1.53±1.13 |
| Right Biceps, kg/min | 9.26±13.17 | -0.73±1.10 |
| Left Biceps, kg/min | 8.1810.09± | -0.54±1.35 |
| Right Tibial, kg/min | 9.28±12.96 | -0.13±1.46 |
| Left Tibial, kg/min | 8.44±17.27 | -1.00±1.41 |
| Six Minute Walk Test, mt | 71.56±50.72 | 2.90±5.48 |
* Significant effect of time, p<0.05
° Significant difference between groups, p<0.05
The cardiovascular and metabolic data of ALS-EP patients; I (initial), F (final); HR 65% (heart rate corresponded to 65% for aerobic training); RHR (Resting heart rate bpm); VO2 (Oxygen Consumption, ml/min/kg); 6 MW (Six Minute Walk Test, mt); MRCss (MRC Sum Score)
| ALS-EP | age | HR 65% | RHR I | RHR F | VO2 I | VO2 F | 6MW I | MRCss I | MRCSs F |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 71 | 95 | 88 | 81 | 13 | 8,1 | 152,5 | 42 | 52 |
| 2 | 54 | 110 | 83 | 78 | 18,1 | 15,4 | 392 | 38 | 50 |
| 3 | 65 | 100 | 89 | 82 | 14,1 | 9 | 294,5 | 41 | 49 |
| 4 | 72 | 95 | 85 | 79 | 12,9 | 12,2 | 316 | 42 | 48 |
| 5 | 53 | 110 | 81 | 77 | 16,4 | 8,6 | 48 | 41 | 49 |
| 6 | 71 | 95 | 78 | 73 | 15,4 | 9,5 | 216 | 36 | 41 |
| 7 | 65 | 100 | 72 | 68 | 17,3 | 11,4 | 256 | 34 | 42 |
| 8 | 68 | 100 | 74 | 67 | 12,8 | 9,3 | 315 | 40 | 48 |
| 9 | 64 | 100 | 78 | 71 | 15,6 | 11,5 | 375 | 40 | 50 |
| 10 | 59 | 105 | 84 | 78 | 16,7 | 13,8 | 340 | 38 | 42 |
| 11 | 73 | 95 | 88 | 81 | 15,9 | 13,1 | 325 | 41 | 52 |
| 12 | 63 | 100 | 83 | 78 | 17,5 | 12,5 | 238 | 38 | 47 |
| 13 | 26 | 125 | 89 | 82 | 17,8 | 13,6 | 275 | 42 | 49 |
| 14 | 67 | 100 | 85 | 79 | 18,3 | 14,3 | 245 | 45 | 52 |
| 15 | 62 | 105 | 81 | 77 | 19,5 | 14,4 | 135 | 41 | 48 |
| 16 | 49 | 110 | 78 | 73 | 14,6 | 10,1 | 305 | 42 | 49 |
| 17 | 57 | 100 | 72 | 68 | 15,2 | 13,1 | 225 | 41 | 48 |
| 18 | 60 | 105 | 74 | 67 | 13,4 | 11,4 | 325 | 42 | 49 |
| 19 | 61 | 105 | 78 | 71 | 13,2 | 9,1 | 225 | 38 | 45 |
| 20 | 74 | 95 | 84 | 78 | 14,6 | 8 | 260 | 42 | 49 |
| 21 | 63 | 105 | 77 | 73 | 14 | 11,2 | 325 | 38 | 46 |
| 22 | 71 | 95 | 76 | 69 | 13,2 | 7,9 | 325 | 42 | 50 |
| 23 | 50 | 110 | 75 | 71 | 13,7 | 8,9 | 186 | 42 | 51 |